EUVIMEDEUVIMED entdecken
Multizentrische Studie

A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Xujun Chu iD, Juan Kang, Jingwen Xu, Haishan Jiang iD, Zhi-Ying Wu iD, Qingping Wang, Wei Li, Jia Li, Xinghua Luan, Chong Sun iD, Zhangyu Zou, Min Zhu und 17 weitere

Annals of Neurology · 2025-06 · 97 (6) · 1158-1167

DOI: 10.1002/ana.27203 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Neurology, online erschienen am 20.02.2025. Verfasst von Xujun Chu und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital), Shanghai Science and Technology Innovation Action Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant genetic disease characterized by the misfolding and deposition of the transthyretin (TTR) protein. This study aimed to describe the clinical and genetic characteristics of ATTRv in a large multicenter Chinese cohort.

Methods

Patients from 14 centers were included in the study. The clinical and genetic characteristics of all patients were summarized. The peripheral blood white blood cell mitochondrial DNA (mtDNA) was detected in offspring from different genders.

Results

A total of 202 individuals with ATTRv from 148 families were identified. The average age of onset was 50.6 ± 12.4 years. Among these cases, 117 (57.9%) were classified as late‐onset (≥50 years) and 85 (42.1%) as early‐onset. Overall, the length dependent axonal sensorimotor peripheral neuropathy was the predominant phenotype (89.1%). A total of 42 heterozygous missense variants and 1 deletion variant were identified. The most common variants were Val30Met (19.8%) and Ala97Ser (15.8%) and patients with Val30Met and Ala97Ser were mostly late‐onset in our cohort. Thirty‐nine of these patients died with a mean age of 56.1 ± 13.5 years. Anticipation according to gender groups of offspring‐parent pairs was different, and mother‐son pairs showed the largest anticipation. The copies of mtDNA in the mother's offspring outnumbered those of the father's offspring ( p < 0.001).

Interpretation

This study highlights that ATTRv patients in China exhibit high heterogeneity in their initial symptoms. The most common variants observed in this cohort is Val30Met. The mtDNA copy number shows gender‐linked effects. These results can impact ATTRv diagnosis and patient care strategies. ANN NEUROL 2025;97:1158–1167

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialPrealbuminHumansFemaleMaleMiddle AgedChinaAdultAgedDNA, MitochondrialAge of OnsetCohort Studies

Substanzen

PrealbuminDNA, MitochondrialTTR protein, human

Autor:innen und Institutionen

  • Department of Neurology, Peking University First Hospital, Beijing, China.
  • The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Health and Rehabilitation Science, School of Life Science and Technology, Xi'an Jiao Tong University, Xi'an, China.
  • Department of Neurology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.
  • Department of Neurology, Qilu Hospital of Shandong University, Jinan, China.
  • Department of Neurology, Nanfang Hospital, Guangzhou, China.
  • Department of Medical Genetics and Center for Rare Diseases, and Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translation in Second Affiliated Hospital, Zhejiang University School of Medi…

ORCID-Profile: Xujun Chu, Haishan Jiang, Zhi-Ying Wu, Chong Sun, Bin Chen, Kang Du, Zaiqiang Zhang, Daojun Hong, Li Cao, Zhaoxia Wang, Yun Yuan, Ruxu Zhang, Lingchao Meng

Förderung

  • National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital)
  • Shanghai Science and Technology Innovation Action Plan

Zitieren

APA

Chu, X., Kang, J., Xu, J., Jiang, H., Wu, Z. Y., Wang, Q., Li, W., Li, J., Luan, X., Sun, C., Zou, Z., Zhu, M., Chen, B., Liu, X., Zhou, M., Du, K., Huang, T., Fan, D., Zhang, Z., …, & Meng, L. (2025). A Multicenter Study of Hereditary Transthyretin Amyloidosis in China. Annals of Neurology, 97(6), 1158-1167. https://doi.org/10.1002/ana.27203

Vancouver

Chu X, Kang J, Xu J, Jiang H, Wu ZY, Wang Q, et al. A Multicenter Study of Hereditary Transthyretin Amyloidosis in China. Annals of Neurology. 2025;97(6):1158-1167. doi:10.1002/ana.27203

BibTeX
@article{Chu2025,
  author = {Chu, Xujun and Kang, Juan and Xu, Jingwen and Jiang, Haishan and Wu, Zhi-Ying and Wang, Qingping and Li, Wei and Li, Jia and Luan, Xinghua and Sun, Chong and Zou, Zhangyu and Zhu, Min and Chen, Bin and Liu, Xiaoxuan and Zhou, Meihong and Du, Kang and Huang, Tao and Fan, Dongsheng and Zhang, Zaiqiang and Hong, Daojun and Lin, Jie and Cao, Li and Qian, Min and Wang, Zhaoxia and Yuan, Yun and Da, Yuwei and Yu, Hao and Zhang, Ruxu and Meng, Lingchao},
  title = {A Multicenter Study of Hereditary Transthyretin Amyloidosis in China},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {97},
  number = {6},
  pages = {1158--1167},
  doi = {10.1002/ana.27203}
}
Kostenlos starten →